Will CSF analysis become routine in people with memory complaints?
Gauthier
Serge
S
D000368:Aged; D000544:Alzheimer Disease / Q000134:cerebrospinal fluid* / Q000175:diagnosis* / Q000503:physiopathology; D016229:Amyloid beta-Peptides / Q000032:analysis / Q000134:cerebrospinal fluid*; D015415:Biomarkers / Q000032:analysis / Q000134:cerebrospinal fluid; D001921:Brain / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D003072:Cognition Disorders / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000503:physiopathology; D018450:Disease Progression; D006801:Humans; D008137:Longitudinal Studies; D008569:Memory Disorders / Q000134:cerebrospinal fluid* / Q000175:diagnosis* / Q000503:physiopathology; D008991:Monitoring, Physiologic / Q000592:standards / Q000639:trends; D010446:Peptide Fragments / Q000032:analysis / Q000134:cerebrospinal fluid*; D011237:Predictive Value of Tests; D012680:Sensitivity and Specificity; D016875:tau Proteins / Q000032:analysis / Q000134:cerebrospinal fluid*
D016229:Amyloid beta-Peptides; D015415:Biomarkers; D010446:Peptide Fragments; C075222:amyloid beta-protein (1-42); D016875:tau Proteins